Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

Additional phase II data suggest modifications for AVI BioPharma's cancer vaccine

June 1, 1999

Phase II trial of York Medical's cancer vaccine cleared

June 1, 1999

Ilex reports progress on Campath development at annual meeting

May 31, 1999

Encouraging phase I trials results for Prostvac presented at ASCO

May 27, 1999

Antiidiotype cancer vaccine induces immune response and may delay disease progression in MBC

May 27, 1999

Maxim completes first two marketing agreements for Maxamine

May 27, 1999

Additional findings announced for Avax Technologies' cancer vaccine

May 27, 1999

Humanized antibody-cytokine fusion protein demonstrates immunological activity in phase I trial

May 26, 1999

MDX-447 shows promising biological activity in phase I/II trial, results reported at ASCO meeting

May 25, 1999

Betathine trial progressing well

May 24, 1999

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...